Infectious Disease Models and Innovative Therapies

567 papers and 13.9k indexed citations i.

About

In recent decades, authors affiliated with Infectious Disease Models and Innovative Therapies have published 567 papers, which have received a total of 13.9k indexed citations. Scholars at this organization have produced 159 papers in Immunology, 143 papers in Virology and 118 papers in Infectious Diseases on the topics of HIV Research and Treatment (141 papers), Immune Cell Function and Interaction (66 papers) and T-cell and B-cell Immunology (57 papers). Their work is cited by papers focused on Immunology (3.7k citations), Molecular Biology (3.4k citations) and Infectious Diseases (3.2k citations). Authors at Infectious Disease Models and Innovative Therapies collaborate with scholars in France, United States and United Kingdom and have published in prestigious journals including Nature, Cell and Proceedings of the National Academy of Sciences. Some of Infectious Disease Models and Innovative Therapies's most productive authors include Roger Le Grand, Pierre Roques, Olivier Lambotte, Nathalie Rouas‐Freiss, Philippe Leboulch, Edgardo D. Carosella, Benoı̂t Favier, Joël LeMaoult, Nathalie Dereuddre‐Bosquet and Gabriel Gras.

In The Last Decade

Fields of papers published by authors at Infectious Disease Models and Innovative Therapies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Infectious Disease Models and Innovative Therapies at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Infectious Disease Models and Innovative Therapies at the time of their publication.

Countries citing scholars working at Infectious Disease Models and Innovative Therapies

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Infectious Disease Models and Innovative Therapies. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Infectious Disease Models and Innovative Therapies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Infectious Disease Models and Innovative Therapies more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025